Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing

Detailed price information for Microbix Biosystems Inc (MBXBF) from The Globe and Mail including charting and trades.

Javelin Sciences Becomes the First U.S. Laboratory to Offer Testing for SARS-CoV-2 Spike Protein in Serum and Exosomes

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
News Medical

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

In a recent study posted to the medRxiv preprint* server, researchers pursued evidence of whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens, of which spike (S) protein is ...
The New England Journal of Medicine

Persistent False Positive Covid-19 Rapid Antigen Tests

Rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective tools for the diagnosis of acute infection, particularly when used serially. 1 The percentage of ...

WHO prequalifies first rapid antigen tests for COVID-19, strengthening global diagnostic preparedness

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...
Healio

SARS-CoV-2 protein detectable in COVID-19 patients up to 14 months after illness

Please provide your email address to receive an email when new articles are posted on . Of plasma samples taken after COVID-19 infection, 7.5% to 12.6% contained detectable viral antigens. Researchers ...